Literature DB >> 25589551

Mapping antigenic motifs in the trypomastigote small surface antigen from Trypanosoma cruzi.

Virginia Balouz1, María de Los Milagros Cámara1, Gaspar E Cánepa1, Santiago J Carmona1, Romina Volcovich2, Nicolás Gonzalez2, Jaime Altcheh2, Fernán Agüero1, Carlos A Buscaglia3.   

Abstract

The trypomastigote small surface antigen (TSSA) is a mucin-like molecule from Trypanosoma cruzi, the etiological agent of Chagas disease, which displays amino acid polymorphisms in parasite isolates. TSSA expression is restricted to the surface of infective cell-derived trypomastigotes, where it functions as an adhesin and engages surface receptors on the host cell as a prerequisite for parasite internalization. Previous results have established TSSA-CL, the isoform encoded by the CL Brener clone, as an appealing candidate for use in serology-based diagnostics for Chagas disease. Here, we used a combination of peptide- and recombinant protein-based tools to map the antigenic structure of TSSA-CL at maximal resolution. Our results indicate the presence of different partially overlapping B-cell epitopes clustering in the central portion of TSSA-CL, which contains most of the polymorphisms found in parasite isolates. Based on these results, we assessed the serodiagnostic performance of a 21-amino-acid-long peptide that spans TSSA-CL major antigenic determinants, which was similar to the performance of the previously validated glutathione S-transferase (GST)-TSSA-CL fusion molecule. Furthermore, the tools developed for the antigenic characterization of the TSSA antigen were also used to explore other potential diagnostic applications of the anti-TSSA humoral response in Chagasic patients. Overall, our present results provide additional insights into the antigenic structure of TSSA-CL and support this molecule as an excellent target for molecular intervention in Chagas disease.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25589551      PMCID: PMC4340888          DOI: 10.1128/CVI.00684-14

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  43 in total

Review 1.  Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests.

Authors:  M Greiner; D Pfeiffer; R D Smith
Journal:  Prev Vet Med       Date:  2000-05-30       Impact factor: 2.670

2.  Multiple overlapping epitopes in the repetitive unit of the shed acute-phase antigen from Trypanosoma cruzi enhance its immunogenic properties.

Authors:  P Alvarez; M S Leguizamón; C A Buscaglia; T A Pitcovsky; O Campetella
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

3.  A functional network of intramolecular cross-reacting epitopes delays the elicitation of neutralizing antibodies to Trypanosoma cruzi trans-sialidase.

Authors:  Tamara A Pitcovsky; Carlos A Buscaglia; Juan Mucci; Oscar Campetella
Journal:  J Infect Dis       Date:  2002-07-17       Impact factor: 5.226

4.  Diagnosis of Chagas disease: what has been achieved? What remains to be done with regard to diagnosis and follow up studies?

Authors:  Yara M Gomes; Virginia M B Lorena; Alejandro O Luquetti
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-07       Impact factor: 2.743

5.  Real time PCR strategy for the identification of major lineages of Trypanosoma cruzi directly in chronically infected human tissues.

Authors:  J M Freitas; E Lages-Silva; E Crema; S D J Pena; A M Macedo
Journal:  Int J Parasitol       Date:  2004-12-08       Impact factor: 3.981

Review 6.  Chagas disease: recombinant Trypanosoma cruzi antigens for serological diagnosis.

Authors:  J F da Silveira; E S Umezawa; A O Luquetti
Journal:  Trends Parasitol       Date:  2001-06

7.  Utility of the Trypanosoma cruzi sequence database for identification of potential vaccine candidates by in silico and in vitro screening.

Authors:  Vandanajay Bhatia; Mala Sinha; Bruce Luxon; Nisha Garg
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

Review 8.  Trypanosoma cruzi clonal diversity and the epidemiology of Chagas' disease.

Authors:  Carlos A Buscaglia; Javier M Di Noia
Journal:  Microbes Infect       Date:  2003-04       Impact factor: 2.700

9.  Congenital Chagas' disease: diagnostic and clinical aspects.

Authors:  H Freilij; J Altcheh
Journal:  Clin Infect Dis       Date:  1995-09       Impact factor: 9.079

10.  A Trypanosoma cruzi small surface molecule provides the first immunological evidence that Chagas' disease is due to a single parasite lineage.

Authors:  Javier M Di Noia; Carlos A Buscaglia; Claudia R De Marchi; Igor C Almeida; Alberto C C Frasch
Journal:  J Exp Med       Date:  2002-02-18       Impact factor: 14.307

View more
  15 in total

1.  Towards High-throughput Immunomics for Infectious Diseases: Use of Next-generation Peptide Microarrays for Rapid Discovery and Mapping of Antigenic Determinants.

Authors:  Santiago J Carmona; Morten Nielsen; Claus Schafer-Nielsen; Juan Mucci; Jaime Altcheh; Virginia Balouz; Valeria Tekiel; Alberto C Frasch; Oscar Campetella; Carlos A Buscaglia; Fernán Agüero
Journal:  Mol Cell Proteomics       Date:  2015-04-28       Impact factor: 5.911

2.  An immunoinformatic approach for identification of Trypanosoma cruzi HLA-A2-restricted CD8(+) T cell epitopes.

Authors:  Christopher S Eickhoff; Daniel Van Aartsen; Frances E Terry; Sheba K Meymandi; Mahmoud M Traina; Salvador Hernandez; William D Martin; Leonard Moise; Annie S De Groot; Daniel F Hoft
Journal:  Hum Vaccin Immunother       Date:  2015-06-24       Impact factor: 3.452

Review 3.  Chagas Disease Diagnostic Applications: Present Knowledge and Future Steps.

Authors:  V Balouz; F Agüero; C A Buscaglia
Journal:  Adv Parasitol       Date:  2016-11-14       Impact factor: 3.870

Review 4.  Parasite-host glycan interactions during Trypanosoma cruzi infection: trans-Sialidase rides the show.

Authors:  Oscar Campetella; Carlos A Buscaglia; Juan Mucci; María Susana Leguizamón
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-01-20       Impact factor: 5.187

5.  The Trypomastigote Small Surface Antigen from Trypanosoma cruzi Improves Treatment Evaluation and Diagnosis in Pediatric Chagas Disease.

Authors:  Virginia Balouz; Luciano J Melli; Romina Volcovich; Guillermo Moscatelli; Samanta Moroni; Nicolás González; Griselda Ballering; Margarita Bisio; Andrés E Ciocchini; Carlos A Buscaglia; Jaime Altcheh
Journal:  J Clin Microbiol       Date:  2017-10-04       Impact factor: 5.948

Review 6.  Serological Approaches for Trypanosoma cruzi Strain Typing.

Authors:  Virginia Balouz; Leonel Bracco; Alejandro D Ricci; Guadalupe Romer; Fernán Agüero; Carlos A Buscaglia
Journal:  Trends Parasitol       Date:  2021-01-09

7.  A Novel Trypanosoma cruzi Protein Associated to the Flagellar Pocket of Replicative Stages and Involved in Parasite Growth.

Authors:  Ignacio M Durante; María de Los Milagros Cámara; Carlos A Buscaglia
Journal:  PLoS One       Date:  2015-06-18       Impact factor: 3.240

8.  The Trypomastigote Small Surface Antigen (TSSA) regulates Trypanosoma cruzi infectivity and differentiation.

Authors:  María de Los Milagros Cámara; Gaspar E Cánepa; Andrés B Lantos; Virginia Balouz; Hai Yu; Xi Chen; Oscar Campetella; Juan Mucci; Carlos A Buscaglia
Journal:  PLoS Negl Trop Dis       Date:  2017-08-11

9.  An ImmunoSignature test distinguishes Trypanosoma cruzi, hepatitis B, hepatitis C and West Nile virus seropositivity among asymptomatic blood donors.

Authors:  Michael Rowe; Jonathan Melnick; Robert Gerwien; Joseph B Legutki; Jessica Pfeilsticker; Theodore M Tarasow; Kathryn F Sykes
Journal:  PLoS Negl Trop Dis       Date:  2017-09-05

10.  Next-generation ELISA diagnostic assay for Chagas Disease based on the combination of short peptidic epitopes.

Authors:  Juan Mucci; Santiago J Carmona; Romina Volcovich; Jaime Altcheh; Estefanía Bracamonte; Jorge D Marco; Morten Nielsen; Carlos A Buscaglia; Fernán Agüero
Journal:  PLoS Negl Trop Dis       Date:  2017-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.